Quality of life after surgery for graves' disease: Comparison of those having surgery intended to preserve thyroid function with those having ablative surgery

Thyroid

Volumn 22, Issue 5, 2012, Pages 494-500

  Al Adhami, Ahmed ^a   Craig, Wendy ^a   Krukowski, Zygmunt H ^a  

^a ABERDEEN ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ABLATION THERAPY; ADULT; ARTICLE; CONTROLLED STUDY; DUNHILL PROCEDURE; FEMALE; FOLLOW UP; GRAVES DISEASE; HEALTH CARE POLICY; HUMAN; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; POSTOPERATIVE PERIOD; PRIORITY JOURNAL; QUALITY OF LIFE; SHORT FORM 36; SUBTOTAL THYROIDECTOMY; SURGICAL TECHNIQUE; THYROID FUNCTION; THYROIDECTOMY; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; ADULT; AGED; ALGORITHMS; CHILD; COST-BENEFIT ANALYSIS; CROSS-SECTIONAL STUDIES; FEMALE; GRAVES DISEASE; HUMANS; MALE; MIDDLE AGED; QUALITY OF LIFE; QUESTIONNAIRES; RECURRENCE; THYROID GLAND; TIME FACTORS;

EID: 84860448368     PISSN: 10507256     EISSN: 15579077     Source Type: Journal    
DOI: 10.1089/thy.2011.0153     Document Type: Article

References (32)

1. Brent GA 2008 Graves' disease. N Engl J Med 358:2594-2605.
2. Cusick EL, Krukowski ZH, Matheson NA 1987 Outcome of surgery for Graves' disease re-examined. Br J Surg 74:780-783.
3. Sitharthan T, Krukowski Z 1999 Evolving practice in surgery for Graves' disease. Br J Surg 86:1221 (abstract).
4. Michie W, Pegg CAS, Bewsher PD 1972 Prediction of hypothyroidism after partial thyroidectomy for thyrotoxicosis. BMJ 1:13-17.
5. Urbach DR 2005 Measuring quality of life after surgery. Surg Innov 12:161-165.
6. Camilleri-Brennan J, Steele RJ 1999 Measurement of quality of life in surgery. J R Coll Surg Edinb 44:252-259.
7. U.K. Department of Health 2005 Creating a patient-led NHS: delivering the NHS Improvement Plan. www.dh.gov.uk/ publications
8. Stalberg P, Svensson A, Hessman O, Akerstrom G, Hellman P 2008 Surgical treatment of Graves' disease: evidence-based approach. World J Surg 32:1269-1277.
9. Schussler-Fiorenza CM, Bruns CM, Chen H 2006 The surgical management of Graves' disease. J Surg Res 133:207-214.
10. In H, Pearce EN, Wong AK, Burgess JF, McAneny DB, Rosen JE 2009 Treatment options for Graves disease: a costeffectiveness analysis. J Am Coll Surg 209:170-179.e1-e2.
11. Jenkinson C, Stewart-Brown S, Petersen S, Paice C 1999 Assessment of the SF-36 version 2 in the United Kingdom. J Epidemiol Community Health 53:46-50.
12. Bahn RS, Burch HB, Cooper DS, Garber JR, Greenlee MC, Klein I, Laurberg P, McDougall IR, Montori VM, Rivkees SA, Ross DS, Sosa JA, Stan MN 2011 Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists. Thyroid 21:593-646.
13. Patel AA, Donegan D, Albert T 2007 The 36-item short form. J Am Acad Orthop Surg 15:126-134.
14. Carr AJ, Higginson IJ 2001 Measuring quality of life: are quality of life measures patient centred? BMJ 322:1357-1360.
15. Adler JT, Sippel RS, Schaefer S, Chen H 2008 Preserving function and quality of life after thyroid and parathyroid surgery. Lancet Oncol 9:1069-1075.
16. Abraham-Nordling M, Wallin G, Lundell G, Torring O 2007 Thyroid hormone state and quality of life at long-term follow-up after randomized treatment of Graves' disease. Eur J Endocrinol 156:173-179.
17. Elberling T, Rasmussen A, Feldt-Rasmussen U, Hording M, Perrild H, Waldemar G 2004 Impaired health-related quality of life in Graves' disease. A prospective study. Eur J Endocrinol 151:549-555.
18. Gulseren S, Gulseren L, Hekimsoy Z, Cetinay P, Ozen C, Tokatlioglu B 2006 Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch Med Res 37:133-139.
19. Terwee CB, Gerding MN, Dekker FW, Prummel MF, Wiersinga WM 1998 Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL. Br J Ophthalmol 82:773-779.
20. Gerding MN, Terwee CB, Dekker FW, Koornneef L, Prummel MF, Wiersinga WM 1997 Quality of life in patients with Graves' ophthalmopathy is markedly decreased: measurement by the medical outcomes study instrument. Thyroid 7:885-889.
21. Kahaly GJ, Hardt J, Petrak F, Egle UT 2002 Psychosocial factors in subjects with thyroid-associated ophthalmopathy. Thyroid 12:237-239.
22. Egle UT, Kahaly GJ, Petrak F, Hardt J, Batke J, Best J, Rothenbacher M 1999 The relevance of physical and psychosocial factors for the quality of life in patients with thyroid-associated orbitopathy (TAO). Exp Clin Endocrinol Diabetes 107:S168-S171.
23. Abraham-Nordling M, Torning O, Hamberger B, Lundell G, Tallstedt L, Calissendorff J, Wallin G 2005 Graves' disease: A long-term quality-of-life follow up of patients randomized to treatment with antithyroid drugs radioiodine or surgery. Thyroid 15:1279.
24. Ljunggren J, Törring O, Wallin G, Taube A, Tallstedt L, Hamberger B, Lundell G 1998 Quality of life aspects and costs in treatment of Graves' hyperthyroidism with antithyroid drugs, surgery, or radioiodine: results from a prospective, randomized study. Thyroid 8:653.
25. Andaker L, Johansson K, Smeds S, Lennquist S 1992 Surgery for hyperthyroidism: hemithyroidectomy plus contralateral resection or bilateral resection? A prospective randomized study of postoperative complications and long-term results. World J Surg 16:765-769.
26. Muller PE, Bein B, Robens E, Bein HS, Spelsberg F 2001 Thyroid surgery according to Enderlen-Hotz or Dunhill: A comparison of two surgical methods for the treatment of Graves' disease. Int Surg 86:112-116.
27. Paganini-Hill A, Hsu G, Chao A, Ross RK 1993 Comparison of early and late respondents to a postal health survey questionnaire. Epidemiology 4:375-379.
28. Edwards P, Roberts I, Clarke M, DiGuiseppi C, Pratap S, Wentz R, Kwan I 2002 Increasing response rates to postal questionnaires: systematic review. BMJ 324:1183.
29. Nakash RA, Hutton JL, Jorstad-Stein EC, Gates S, Lamb SE 2006 Maximising response to postal questionnaires-a systematic review of randomised trials in health research. BMC Med Res Methodol 6:5.
30. Schulz KF, Grimes DA 2002 Sample size slippages in randomized trials: exclusions and the lost and wayward. Lancet 359:781-785.
31. Patrick DL, Deyo RA 1989 Generic and disease-specific measures in assessing health status and quality of life. Med Care 27:S217-S232.
32. Ware JE 2000 SF-36 health survey update. Spine 25:3130.